Multipotent stem cells and uses thereof
AssigneeThe Brigham and Women's Hospital, Inc.
InventorsKeith D. Crawford, Christopher Southgate
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Brigham and Women's Hospital, Inc.
InventorsKeith D. Crawford, Christopher Southgate
Estimating the term…
The invention provides a quiescent stem cell having the capacity to differentiate into ectoderm, mesoderm and endoderm, and which does not express cell surface markers including MHC class I, MHC class II, CD44, CD45, CD13, CD34, CD49c, CD73, CD105 and CD90. The invention further provides a proliferative stem cell, which expresses genes including Oct-4, Nanog, Sox2, GDF3, P16INK4, BMI, Notch, HDAC4, TERT, Rex-1 and TWIST but does not express cell surface markers including MHC class I, MHC class II, CD44, CD45, CD13, CD34, CD49c, CD73, CD105 and CD90. The cells of the invention can be isolated from adult mammals, have embryonic cell characteristics, and can form embryoid bodies. Methods for obtaining the stem cells, as well as methods of treating diseases and the differentiated stem cells, are also provided.
A tissue regenerative formulation comprising:
Dependencies are inferred from the claim text.